Trials / Unknown
UnknownNCT05107921
Bromfenac Sodium Hydrate Eye Drops in Familial Exudative Vitreoretinopathy
Efficacy of Bromfenac Sodium Hydrate Eye Drops in Children With Familial Exudative Vitreoretinopathy After Diode Laser Photocoagulation
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 39 (estimated)
- Sponsor
- Seoul National University Hospital · Academic / Other
- Sex
- All
- Age
- 1 Month – 7 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to investigate the efficacy and safety of bromfenac sodium hydrate eye drops in patients with familial exudative vitreoretinopathy receiving diode laser photocoagulation.
Detailed description
This study aims to evaluate the presence of macular edema as the primary measure and the presence of conjunctival injection as the secondary measure for the investigation of the efficacy of bromfenac sodium hydrate eye drops in patients with familial exudative vitreoretinopathy receiving diode laser photocoagulation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bromfenac Sodium | The study participants will receive bromfenac sodium hydrate eyedrops twice daily for 14 days. |
Timeline
- Start date
- 2021-11-01
- Primary completion
- 2024-10-20
- Completion
- 2024-10-20
- First posted
- 2021-11-04
- Last updated
- 2023-11-22
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05107921. Inclusion in this directory is not an endorsement.